CTRI/2015/06/005945已完成4 期
A multi-center, open-label, observational study to evaluate the efficacy and safety of intravitreal injections (IVI) of Ranibizumab in patients with visual impairment due to Diabetic Macular Edema (DME) - UNVEIL- DME
ovartis Healthcare Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Patients willing to provide signed, written informed consent
- •2.Patients with macular edema due to Diabetes (confirmed by fundus photography, fluorescein angiography, OCT)
- •3.Male and female aged 18 and above.
- •4.Vision Impairment due to DME (PL + to 6/9 on Snellen chart).
排除标准
- •1. Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent the improvement of visual acuity on study treatment.
- •2. Active intraocular inflammation in either eye.
- •3. Uncontrolled glaucoma in the study eye.
- •4. Active proliferative diabetic retinopathy in the study eye.
- •5. Any contra-indication according to local Summary of Product Characteristics or Prescribing Information (SmPC or PI) of ranibizumab.
研究者
相似试验
招募中
不适用
Multi-centered open-label, observational study of Sitagliptin in West Tokyo AreaType2 diabetesJPRN-UMIN000003362Tama-center Mirai Clinic100
已完成
4 期
An observational study to assess the profile of ranibizumab in patients with retinal vein occlusion in a real-world setting.CTRI/2015/07/005985ovartis Healthcare Pvt Ltd100
进行中（未招募）
1 期
A study to evaluate the efficacy and safety of ibrutinib and ofatumumab in untreated patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma.EUCTR2016-004937-26-ESFundación PETHEMA
招募中
4 期
To find the effectiveness and safety of nefopam tablet in pain associated with trauma.CTRI/2019/06/019801Abbott India Ltd
进行中（未招募）
不适用
A prospective, multi-centre, open-label study to establish the equipotent dose ratio after switching from strong opioids to Transtec® in subjects with pain due to cancer - Transtec® in Cancer paicancer painEUCTR2004-004624-13-GBBarts and The London NHS Trust180